Valuation IDEXX Laboratories, Inc. Sao Paulo
Stocks
I1DX34
BRI1DXBDR001
Medical Equipment, Supplies & Distribution
|
Market Closed -
Sao Paulo
11:36:20 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 546.43 BRL | +2.81% |
|
+5.82% | -27.66% |
| 10-20 | Jefferies Adjusts Price Target on IDEXX Laboratories to $705 From $795 | MT |
| 10-16 | JPMorgan Adjusts Price Target on IDEXX Laboratories to $750 From $775 | MT |
Company Valuation: IDEXX Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 55,833 | 33,786 | 46,098 | 33,854 | 54,022 | 43,787 | - | - |
| Change | - | -39.49% | 36.44% | -26.56% | 59.57% | -18.95% | - | - |
| Enterprise Value (EV) 1 | 56,612 | 35,022 | 46,592 | 34,434 | 54,690 | 44,154 | 43,688 | 42,887 |
| Change | - | -38.14% | 33.04% | -26.09% | 58.83% | -19.26% | -1.06% | -1.83% |
| P/E | 76.6x | 50.8x | 55.2x | 38.7x | 51.7x | 37.8x | 33.5x | 29.6x |
| PBR | 82.6x | 55.6x | 31x | 21.6x | 34.1x | 22.2x | 16.4x | 12x |
| PEG | - | -7.66x | 2.2x | 6.38x | 2.3x | 2.9x | 2.6x | 2.3x |
| Capitalization / Revenue | 17.4x | 10x | 12.6x | 8.69x | 12.6x | 9.27x | 8.51x | 7.8x |
| EV / Revenue | 17.6x | 10.4x | 12.7x | 8.83x | 12.7x | 9.35x | 8.49x | 7.64x |
| EV / EBITDA | 54.6x | 34.7x | 38.4x | 28.1x | 36.3x | 26.1x | 23.5x | 20.9x |
| EV / EBIT | 60.7x | 39x | 42.5x | 30.5x | 40.2x | 28.9x | 25.8x | 22.7x |
| EV / FCF | 89x | 88.9x | 60.3x | 42.6x | 51.7x | 37.6x | 33.4x | 29.3x |
| FCF Yield | 1.12% | 1.13% | 1.66% | 2.35% | 1.93% | 2.66% | 2.99% | 3.41% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 8.6 | 8.03 | 10.06 | 10.67 | 13.08 | 14.77 | 16.66 | 18.85 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3,215 | 3,367 | 3,661 | 3,898 | 4,304 | 4,725 | 5,145 | 5,612 |
| EBITDA 1 | 1,037 | 1,011 | 1,212 | 1,225 | 1,505 | 1,689 | 1,855 | 2,057 |
| EBIT 1 | 932 | 898.8 | 1,097 | 1,128 | 1,360 | 1,527 | 1,693 | 1,889 |
| Net income 1 | 744.8 | 679.1 | 845 | 887.9 | 1,059 | 1,179 | 1,312 | 1,465 |
| Net Debt 1 | 779.2 | 1,236 | 493.9 | 579.3 | 667.8 | 367.6 | -98.49 | -899.7 |
| Reference price 2 | 658.46 | 407.96 | 555.05 | 413.44 | 676.53 | 557.89 | 557.89 | 557.89 |
| Nbr of stocks (in thousands) | 84,794 | 82,817 | 83,052 | 81,885 | 79,851 | 78,781 | - | - |
| Announcement Date | 2/2/22 | 2/6/23 | 2/5/24 | 2/3/25 | 2/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.7x | 4.06x | 15.71x | 2.44% | 180B | |
| 19.83x | 3.46x | 12.37x | 3.06% | 114B | |
| 23.23x | 4.55x | 15.85x | 1.21% | 114B | |
| 26.93x | 2.64x | 10.6x | 2.68% | 78.39B | |
| 18.65x | 0.21x | 13.46x | 0.7% | 64.88B | |
| 31.09x | 7.72x | 19.92x | 1.28% | 54.02B | |
| 36.76x | 3.52x | 12.05x | 2.06% | 51.96B | |
| 37.64x | 9.35x | 26.14x | -.--% | 43.79B | |
| 34.55x | 6.06x | 19.02x | -.--% | 32.45B | |
| Average | 28.82x | 4.62x | 16.13x | 1.49% | 81.49B | |
| Weighted average by Cap. | 27.43x | 4.19x | 15.29x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IDXX Stock
- I1DX34 Stock
- Valuation IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
